Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy-based Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Viral Gene Delivery System
1.2.3 Non-viral Gene Delivery System
1.3 Market by Application
1.3.1 Global Gene Therapy-based Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy-based Drug Market Perspective (2018-2029)
2.2 Global Gene Therapy-based Drug Growth Trends by Region
2.2.1 Gene Therapy-based Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy-based Drug Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy-based Drug Market Dynamics
2.3.1 Gene Therapy-based Drug Industry Trends
2.3.2 Gene Therapy-based Drug Market Drivers
2.3.3 Gene Therapy-based Drug Market Challenges
2.3.4 Gene Therapy-based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy-based Drug by Players
3.1.1 Global Gene Therapy-based Drug Revenue by Players (2018-2024)
3.1.2 Global Gene Therapy-based Drug Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapy-based Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy-based Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Gene Therapy-based Drug Market Concentration Ratio
3.4.1 Global Gene Therapy-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy-based Drug Revenue in 2022
3.5 Global Key Players of Gene Therapy-based Drug Head office and Area Served
3.6 Global Key Players of Gene Therapy-based Drug, Product and Application
3.7 Global Key Players of Gene Therapy-based Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy-based Drug Breakdown Data by Type
4.1 Global Gene Therapy-based Drug Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029)
5 Gene Therapy-based Drug Breakdown Data by Application
5.1 Global Gene Therapy-based Drug Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy-based Drug Market Size (2018-2029)
6.2 North America Gene Therapy-based Drug Market Size by Type
6.2.1 North America Gene Therapy-based Drug Market Size by Type (2018-2024)
6.2.2 North America Gene Therapy-based Drug Market Size by Type (2024-2029)
6.2.3 North America Gene Therapy-based Drug Market Share by Type (2018-2029)
6.3 North America Gene Therapy-based Drug Market Size by Application
6.3.1 North America Gene Therapy-based Drug Market Size by Application (2018-2024)
6.3.2 North America Gene Therapy-based Drug Market Size by Application (2024-2029)
6.3.3 North America Gene Therapy-based Drug Market Share by Application (2018-2029)
6.4 North America Gene Therapy-based Drug Market Size by Country
6.4.1 North America Gene Therapy-based Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Therapy-based Drug Market Size by Country (2018-2024)
6.4.3 North America Gene Therapy-based Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy-based Drug Market Size (2018-2029)
7.2 Europe Gene Therapy-based Drug Market Size by Type
7.2.1 Europe Gene Therapy-based Drug Market Size by Type (2018-2024)
7.2.2 Europe Gene Therapy-based Drug Market Size by Type (2024-2029)
7.2.3 Europe Gene Therapy-based Drug Market Share by Type (2018-2029)
7.3 Europe Gene Therapy-based Drug Market Size by Application
7.3.1 Europe Gene Therapy-based Drug Market Size by Application (2018-2024)
7.3.2 Europe Gene Therapy-based Drug Market Size by Application (2024-2029)
7.3.3 Europe Gene Therapy-based Drug Market Share by Application (2018-2029)
7.4 Europe Gene Therapy-based Drug Market Size by Country
7.4.1 Europe Gene Therapy-based Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Therapy-based Drug Market Size by Country (2018-2024)
7.4.3 Europe Gene Therapy-based Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy-based Drug Market Size (2018-2029)
8.2 China Gene Therapy-based Drug Market Size by Type
8.2.1 China Gene Therapy-based Drug Market Size by Type (2018-2024)
8.2.2 China Gene Therapy-based Drug Market Size by Type (2024-2029)
8.2.3 China Gene Therapy-based Drug Market Share by Type (2018-2029)
8.3 China Gene Therapy-based Drug Market Size by Application
8.3.1 China Gene Therapy-based Drug Market Size by Application (2018-2024)
8.3.2 China Gene Therapy-based Drug Market Size by Application (2024-2029)
8.3.3 China Gene Therapy-based Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene Therapy-based Drug Market Size (2018-2029)
9.2 Asia Gene Therapy-based Drug Market Size by Type
9.2.1 Asia Gene Therapy-based Drug Market Size by Type (2018-2024)
9.2.2 Asia Gene Therapy-based Drug Market Size by Type (2024-2029)
9.2.3 Asia Gene Therapy-based Drug Market Share by Type (2018-2029)
9.3 Asia Gene Therapy-based Drug Market Size by Application
9.3.1 Asia Gene Therapy-based Drug Market Size by Application (2018-2024)
9.3.2 Asia Gene Therapy-based Drug Market Size by Application (2024-2029)
9.3.3 Asia Gene Therapy-based Drug Market Share by Application (2018-2029)
9.4 Asia Gene Therapy-based Drug Market Size by Region
9.4.1 Asia Gene Therapy-based Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Therapy-based Drug Market Size by Region (2018-2024)
9.4.3 Asia Gene Therapy-based Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy-based Drug Introduction
11.1.4 Biogen Revenue in Gene Therapy-based Drug Business (2018-2024)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy-based Drug Introduction
11.2.4 Novartis Revenue in Gene Therapy-based Drug Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy-based Drug Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2024)
11.3.5 Gilead Sciences Recent Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy-based Drug Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy-based Drug Introduction
11.6.4 Amgen Revenue in Gene Therapy-based Drug Business (2018-2024)
11.6.5 Amgen Recent Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy-based Drug Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.7.5 Spark Therapeutics Recent Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy-based Drug Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy-based Drug Introduction
11.9.4 bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2024)
11.9.5 bluebird bio Recent Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy-based Drug Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2024)
11.10.5 Sunway Biotech Recent Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy-based Drug Introduction
11.11.4 SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2024)
11.11.5 SIBIONO Recent Developments
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy-based Drug Introduction
11.12.4 AnGes Revenue in Gene Therapy-based Drug Business (2018-2024)
11.12.5 AnGes Recent Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy-based Drug Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024)
11.13.5 Orchard Therapeutics Recent Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy-based Drug Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2024)
11.14.5 Human Stem Cells Institute Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Delivery System
Table 3. Key Players of Non-viral Gene Delivery System
Table 4. Global Gene Therapy-based Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene Therapy-based Drug Market Share by Region (2018-2024)
Table 8. Global Gene Therapy-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy-based Drug Market Share by Region (2024-2029)
Table 10. Gene Therapy-based Drug Market Trends
Table 11. Gene Therapy-based Drug Market Drivers
Table 12. Gene Therapy-based Drug Market Challenges
Table 13. Gene Therapy-based Drug Market Restraints
Table 14. Global Gene Therapy-based Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene Therapy-based Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Gene Therapy-based Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Table 17. Global Gene Therapy-based Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy-based Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Gene Therapy-based Drug, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy-based Drug, Product and Application
Table 21. Global Key Players of Gene Therapy-based Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene Therapy-based Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Gene Therapy-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy-based Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene Therapy-based Drug Revenue Share by Application (2018-2024)
Table 29. Global Gene Therapy-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy-based Drug Revenue Share by Application (2024-2029)
Table 31. North America Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Gene Therapy-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Gene Therapy-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Gene Therapy-based Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Gene Therapy-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Gene Therapy-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Gene Therapy-based Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Gene Therapy-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Gene Therapy-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Gene Therapy-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Gene Therapy-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Gene Therapy-based Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Gene Therapy-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Gene Therapy-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Therapy-based Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. Biogen Company Details
Table 64. Biogen Business Overview
Table 65. Biogen Gene Therapy-based Drug Product
Table 66. Biogen Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 67. Biogen Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Gene Therapy-based Drug Product
Table 71. Novartis Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Gilead Sciences Company Details
Table 74. Gilead Sciences Business Overview
Table 75. Gilead Sciences Gene Therapy-based Drug Product
Table 76. Gilead Sciences Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 77. Gilead Sciences Recent Developments
Table 78. Sarepta Therapeutics Company Details
Table 79. Sarepta Therapeutics Business Overview
Table 80. Sarepta Therapeutics Gene Therapy-based Drug Product
Table 81. Sarepta Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 82. Sarepta Therapeutics Recent Developments
Table 83. Alnylam Pharmaceuticals Company Details
Table 84. Alnylam Pharmaceuticals Business Overview
Table 85. Alnylam Pharmaceuticals Gene Therapy-based Drug Product
Table 86. Alnylam Pharmaceuticals Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 87. Alnylam Pharmaceuticals Recent Developments
Table 88. Amgen Company Details
Table 89. Amgen Business Overview
Table 90. Amgen Gene Therapy-based Drug Product
Table 91. Amgen Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 92. Amgen Recent Developments
Table 93. Spark Therapeutics Company Details
Table 94. Spark Therapeutics Business Overview
Table 95. Spark Therapeutics Gene Therapy-based Drug Product
Table 96. Spark Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 97. Spark Therapeutics Recent Developments
Table 98. Akcea Therapeutics Company Details
Table 99. Akcea Therapeutics Business Overview
Table 100. Akcea Therapeutics Gene Therapy-based Drug Product
Table 101. Akcea Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 102. Akcea Therapeutics Recent Developments
Table 103. bluebird bio Company Details
Table 104. bluebird bio Business Overview
Table 105. bluebird bio Gene Therapy-based Drug Product
Table 106. bluebird bio Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 107. bluebird bio Recent Developments
Table 108. Sunway Biotech Company Details
Table 109. Sunway Biotech Business Overview
Table 110. Sunway Biotech Gene Therapy-based Drug Product
Table 111. Sunway Biotech Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 112. Sunway Biotech Recent Developments
Table 113. SIBIONO Company Details
Table 114. SIBIONO Business Overview
Table 115. SIBIONO Gene Therapy-based Drug Product
Table 116. SIBIONO Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 117. SIBIONO Recent Developments
Table 118. AnGes Company Details
Table 119. AnGes Business Overview
Table 120. AnGes Gene Therapy-based Drug Product
Table 121. AnGes Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 122. AnGes Recent Developments
Table 123. Orchard Therapeutics Company Details
Table 124. Orchard Therapeutics Business Overview
Table 125. Orchard Therapeutics Gene Therapy-based Drug Product
Table 126. Orchard Therapeutics Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 127. Orchard Therapeutics Recent Developments
Table 128. Human Stem Cells Institute Company Details
Table 129. Human Stem Cells Institute Business Overview
Table 130. Human Stem Cells Institute Gene Therapy-based Drug Product
Table 131. Human Stem Cells Institute Revenue in Gene Therapy-based Drug Business (2018-2024) & (US$ Million)
Table 132. Human Stem Cells Institute Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy-based Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Therapy-based Drug Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Delivery System Features
Figure 4. Non-viral Gene Delivery System Features
Figure 5. Global Gene Therapy-based Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Gene Therapy-based Drug Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy-based Drug Report Years Considered
Figure 11. Global Gene Therapy-based Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy-based Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy-based Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy-based Drug Market Share by Players in 2022
Figure 15. Global Top Gene Therapy-based Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy-based Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy-based Drug Revenue in 2022
Figure 17. North America Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy-based Drug Market Share by Type (2018-2029)
Figure 19. North America Gene Therapy-based Drug Market Share by Application (2018-2029)
Figure 20. North America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 21. United States Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene Therapy-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Gene Therapy-based Drug Market Share by Type (2018-2029)
Figure 25. Europe Gene Therapy-based Drug Market Share by Application (2018-2029)
Figure 26. Europe Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 27. Germany Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Gene Therapy-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Gene Therapy-based Drug Market Share by Type (2018-2029)
Figure 35. China Gene Therapy-based Drug Market Share by Application (2018-2029)
Figure 36. Asia Gene Therapy-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Gene Therapy-based Drug Market Share by Type (2018-2029)
Figure 38. Asia Gene Therapy-based Drug Market Share by Application (2018-2029)
Figure 39. Asia Gene Therapy-based Drug Market Share by Region (2018-2029)
Figure 40. Japan Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Gene Therapy-based Drug Market Share by Country (2018-2029)
Figure 50. Brazil Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Gene Therapy-based Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Biogen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 58. Gilead Sciences Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 59. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 60. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 61. Amgen Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 62. Spark Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 63. Akcea Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 64. bluebird bio Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 65. Sunway Biotech Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 66. SIBIONO Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 67. AnGes Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 68. Orchard Therapeutics Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 69. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy-based Drug Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed